Lisdexamfetamine, marketed as Vyvanse, is a controlled medication approved for attention deficit hyperactivity disorder in children and individuals. In Canada, its access is managed by Health Canada. This https://order-sandoz-lisdexamfet837103.icingblog.com/61728482/this-medication-in-canada-a-detailed-guide